Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $318.78 USD
Change Today +1.78 / 0.56%
Volume 2.3M
BIIB On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

George A. Scangos Ph.D.

Chief Executive Officer and Director, Biogen Inc.
AgeTotal Calculated CompensationThis person is connected to 131 board members in 8 different organizations across 11 different industries.

See Board Relationships
67$18,631,369
As of Fiscal Year 2014

Background*

Dr. George A. Scangos, Ph.D. has been the Chief Executive Officer at Biogen Inc and Biogen Idec Ltd since July 2010. Dr. Scangos served as the President and Chief Executive Officer of Exelixis, Inc., a holding company of X-ceptor Therapeutics Inc. from October 1996 to July 2010. He served as the President of Biotechnology of Bayer Corporation from September 1993 to October 1996 and was responsible for 1,100 employees in research and development, business development, ...

Read Full Background

Corporate Headquarters*

225 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 617-679-2000
Fax: --

Board Members Memberships*

Vice Chairman
Director
Director
Director
1996-Present
Director
2010-Present
Chief Executive Officer and Director
2010-Present
Chief Executive Officer and Director
2014-Present
Director, Member of Compensation Committee and Member of Nominating/Corporate Governance Committee

Education*

BA
Cornell University
PhD
University Of Massachusetts

Other Affiliations*

Annual Compensation*

Salary$1,375,000
Total Annual Compensation$1,375,000

Stock Options*

Restricted Stock Awards$12,120,939
All Other Compensation$1,001,483

Total Compensation*

Total Annual Cash Compensation$6,423,796
Total Short Term Compensation$1,375,000
Other Long Term Compensation$13,122,422
Total Calculated Compensation$18,631,369
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIIB:US $318.78 USD +1.78

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marc N. Casper Chief Executive Officer, President, Director, Member of Strategy & Finance Committee and Member of Science & Technology Committee
Thermo Fisher Scientific, Inc.
$1.3M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$2.0M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.4M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$3.6M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
¥182.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.